Message from Chairman of the Board of Directors
In 2021, Thailand experienced an immense wave of the COVID-19 pandemic, with numerous infected people receiving medical care and deaths. In the hope of creating herd immunity so as to quickly restore the situation back to normal, the government has urgently upgraded the integrated control measures and hastened the vaccination.
In 2021, Thailand experienced an immense wave of the COVID-19 pandemic, with numerous infected people receiving medical care and deaths. In the hope of creating herd immunity so as to quickly restore the situation back to normal, the government has urgently upgraded the integrated control measures and hastened the vaccination. In this regard, the company and its affiliated hospitals have been providing medical services to alleviate the pandemic situation such as screening, quarantine, medical treatment and vaccination, and have continuously been cooperating with the government in active patient search in high infection areas. The company and its affiliated hospitals have also enhanced our capacity in providing healthcare service to infected patients by increasing number of beds in cohort wards and “hospitel” facilities as well as assisting the local municipalities in providing service in relevant field hospitals.
In addition, in 2021 the company officially opened 2 new hospitals, being (1) Kasemrad Hospital Prachinburi, a 115-bed hospital located in Sri Maha Bodhi District, Prachinburi Province to provide medical services to general patients and patients under the Social Security Scheme and (2) Kasemrad International Hospital Vientiane, a 110-bed hospital located in Vientiane Capital, Lao PDR to provide medical services to local Lao patients and foreign patients in the area.
Our performance during year 2021, under the influence of the COVID-19 situation, in term of revenue and net profit has grown significantly. Total revenue is increased by 138.83 percent, compared to the previous year, to 21,529.40 million baht; net profit is increased by 456.86 percent, to 6,846.00 million baht. This significant growth was driven by a commitment to provide service to non-COVID-19 patients, a full devotion in working with the government to provide medical services related to COVID-19 and our continuity in implementing a cost management policy. The company has also engaged in a management policy so as to increase operational efficiency, securing constant growth in our performance.
Apart from business operations, the company insisted to promote good corporate governance along with upgrading the corporate credit rating. In 2021, the company’s level of good corporate governance has been upgraded from "good" to "very good" by Thai Institute of Directors (IOD). TRIS Rating has also upgraded the company's credit rating from “A-” to “A” with a “stable” outlook. In terms of social responsibility, the company was chosen to be one of 100 listed companies in Stock Exchange of Thailand with an outstanding performance in environment, social, and governance (ESG) from the assessment of Thaipat Institute.
On behalf of Bangkok Chain Hospital Public Company Limited, I would like to convey my gratitude to all shareholders, customers, Financial Institutes, private and public organizations, and business partners for your unwavering trust and supports. Likewise, I would like to express my sincere appreciation to doctors, nurses, and employees for their exertions and dedications to the company.
The company will strictly adhere to the intention to operate the business in line with ethical principles and good corporate governance guidelines to ensure sustainability and stability of the company.